ORIC (ORIC) Stock Price & Analysis
ORIC (ORIC) rose 0.94% to USD 12.86 as of September 8, 2026 at 05:43 UTC, according to Nexqual real-time market data.
ORIC last closed at USD 12.86; the session ranged USD 12.51–12.99 on volume of 991,453 shares. Market capitalization is —, with a 52-week range of USD 7.23–14.93 (NMS). Source: Nexqual, September 8, 2026 at 05:43 UTC.
Key Statistics (as of September 8, 2026 at 05:43 UTC)
| Price | USD 12.86 |
|---|---|
| Change | ▲ 0.94% (up) |
| Previous Close | USD 12.86 |
| Open | USD 12.86 |
| Day Range | USD 12.51 – 12.99 |
| 52-Week Range | USD 7.23 – 14.93 |
| Volume | 991,453 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ORIC)
Nexqual's technical model rates ORIC "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:43 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.18 (neutral) |
| vs SMA50 | Above (USD 12.18) |
| MACD | 0.22 (positive) |
From ORIC's Latest SEC 10-K Filing (filed 2026-02-23)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | USD 26.14 | ▲ 1.24% |
| OLMA | Olema Pharmaceuticals, Inc. | USD 10.75 | ▼ 0.74% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | USD 3.99 | ▲ 5.84% |
| KROS | Keros Therapeutics, Inc. | USD 11.32 | ▲ 0.8% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:43 UTC. This page is informational and not investment advice.